Literature DB >> 8628540

Baltimore Vision Screening Project.

M W Preslan1, A Novak.   

Abstract

PURPOSE: This study estimates the prevalence of common visual disorders (amblyopia, strabismus, refractive errors) in a group of inner-city school children. In addition, the study addresses the issue of access to care for vision-screening programs, specifically for children with recognized difficulties in obtaining routine medical care.
METHODS: School children from an inner-city elementary school were enrolled into a prospective vision-screening program combining the identification arm (screening) and diagnostic/treatment arm (ophthalmic examination). The screening consisted of Snellen E optotypes presented at a 10-foot test distance. Each child failing the vision screening was examined by an ophthalmologist at the school using standard protocol. This allowed the authors to examine all children identified through the vision-screening program.
RESULTS: Six-hundred eighty children were screened during the 1993 to 1994 school year. Eleven percent (76) failed the vision screening and were examined, 68 of whom failed the ophthalmic examination. The estimated prevalence of visual morbidity was as follows: amblyopia, 3.9%; strabismus, 3.1%, and refractive errors, 8.2%.
CONCLUSION: Amblyopia, strasbismus, and refractive errors were found in relatively high frequencies for this population sample of inner city children. These findings underscore the necessity of comprehensive vision-screening programs that integrate follow-up care. Children with limited access to specialized eye care must be provided with a mechanism for obtaining these services.

Entities:  

Mesh:

Year:  1996        PMID: 8628540     DOI: 10.1016/s0161-6420(96)30753-7

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  45 in total

1.  Prevalence of eye diseases in primary school children in a rural area of Tanzania.

Authors:  S H Wedner; D A Ross; R Balira; L Kaji; A Foster
Journal:  Br J Ophthalmol       Date:  2000-11       Impact factor: 4.638

2.  [Examination of preschool children for refractive errors. First experience using a handheld autorefractor].

Authors:  T F Büchner; U Schnorbus; U H Grenzebach; T Stupp; H Busse
Journal:  Ophthalmologe       Date:  2003-11       Impact factor: 1.059

3.  Hyperopic refractive errors as a prognostic factor in intermittent exotropia surgery.

Authors:  M K Kim; U S Kim; M-J Cho; S-H Baek
Journal:  Eye (Lond)       Date:  2015-08-21       Impact factor: 3.775

4.  The development of myopia among children with intermittent exotropia.

Authors:  Noha S Ekdawi; Kevin J Nusz; Nancy N Diehl; Brian G Mohney
Journal:  Am J Ophthalmol       Date:  2010-03       Impact factor: 5.258

5.  A value analysis model applied to the management of amblyopia.

Authors:  G R Beauchamp; M C Bane; D R Stager; P M Berry; W W Wright
Journal:  Trans Am Ophthalmol Soc       Date:  1999

6.  Decreasing strabismus surgery.

Authors:  A Arora; B Williams; A K Arora; R McNamara; J Yates; A Fielder
Journal:  Br J Ophthalmol       Date:  2005-04       Impact factor: 4.638

7.  Prevalence, causes and associations of amblyopia in year 1 students in Central China : The Anyang childhood eye study (ACES).

Authors:  Jing Fu; Shi Ming Li; Si Yuan Li; Jin Ling Li; He Li; Bi Dan Zhu; Zhou Yang; Lei Li; Ning Li Wang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-11-08       Impact factor: 3.117

8.  Motor and sensory characteristics of infantile nystagmus.

Authors:  R V Abadi; A Bjerre
Journal:  Br J Ophthalmol       Date:  2002-10       Impact factor: 4.638

9.  Photorefractive keratectomy for anisometropic amblyopia in children.

Authors:  Evelyn A Paysse
Journal:  Trans Am Ophthalmol Soc       Date:  2004

10.  Amblyopia therapy in Asian children: factors affecting visual outcome and parents' perception of children's attitudes towards amblyopia treatment.

Authors:  Swati Handa; Audrey Chia
Journal:  Singapore Med J       Date:  2018-11-29       Impact factor: 1.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.